missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Polatuzumab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Marque: Invitrogen™ MA558512
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Polatuzumab is a biosimilar that targets CD79B. CD79b is the B cell antigen receptor Ig beta chain (BCR-Ig beta), which associates with B cell antigen receptor Ig alpha chain to form a functional heterodimer that interacts with membrane immunoglobulin (mIg). The mIgM component binds antigen and the Ig alpha /I g beta heterodimer tranduces signals.
Spécification
| Polatuzumab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| Polatuzumab vedotin; polatuzumab vedotin-piiq; POLIVY | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 1 mg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu